Interval debulking surgery, or IDS, is a way to treat advanced – meaning stage III or IV – ovarian cancer when primary surgery isn’t possible. IDS also can be performed as a secondary surgery when ...

New research in the October 2023 issue of JNCCN - Journal of the National Comprehensive Cancer Network finds that intensive local-regional treatment to remove as much tumor as possible (known as ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Survival outcomes for patients with high-grade serous ovarian carcinoma may be ...

Please provide your email address to receive an email when new articles are posted on . No statistically significant differences in health-related quality of life occurred with debulking plus systemic ...

CHICAGO — Tumor debulking does not improve survival in multiorgan metastatic colorectal cancer (CRC), according to a phase 3 trial presented at the American Society of Clinical Oncology (ASCO) 2024 ...

Ovarian cancer is often advanced at the time of diagnosis. Debulking is a surgical procedure that may prevent or delay disease progression. Debulking is a type of surgery that removes as many ovarian ...

A major randomized trial challenges the assumed benefit of tumor debulking in advanced colorectal cancer, showing no survival gain despite increased risks and raising questions about its role in ...

Neoadjuvant chemotherapy with interval debulking surgery is associated with higher complete gross resection rates and lower postoperative mortality in advanced epithelial ovarian cancer. The use of ...

Please provide your email address to receive an email when new articles are posted on . Small, crowded eyes tend to make phacoemulsification challenging. Short axial length coupled with a crowded ...

Neoadjuvant chemotherapy (NACT) is a treatment for advanced ovarian cancer – cancer at stage III or IV. It uses chemo drugs to shrink tumors before any surgery is done to remove them. NACT uses a ...